Douglas Friedman is Executive Director of the Engineering Biology Research Consortium (EBRC) and holds a concurrent appointment as a principal investigator at the University of California, Berkeley. His primary scientific and technical interests lie in the fields of synthetic biology, biotechnology, and physical organic chemistry. Doug’s policy interests include governance of biotechnology, safeguarding the bioeconomy, and accelerating scientific advancement by building diverse, robust community partnerships. He regularly serves as a subject matter expert on emerging biotechnologies, biotechnology policy, and national security topics at the interface of the biological and chemical sciences.
Prior to his role at EBRC, Doug was a study director and senior program officer with the Board on Chemical Sciences and Technology at the National Academies of Sciences, Engineering, and Medicine. He directed 7 major studies and supported numerous workshops and other activities. His primary portfolio focused on science and engineering at the interface of chemistry and biology, often as they related to national security.
Earlier in his career, Doug performed research in physical organic chemistry and chemical biology in academia and industry. He earned a Ph.D. in Chemistry from Northwestern University and a B.S. in Chemical Biology from the University of California, Berkeley.